Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

FORMULATION, OPTIMIZATION, AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS CONTAINING EPLERENONE

View through CrossRef
Objective: The proposed work was aimed at optimization, formulation, and characterization of transdermal patches of eplerenone for efficient transdermal delivery of the drug. Methods: The log p estimation of eplerenone is 1.34, it was closer to standard worth. Log P value in a range of 1 to 4 indicates higher permeation through the skin. FTIIR study was carried out individually for drug, each polymer, and finished product (Patches) compared eplerenone and FTIR spectra of pure drug and polymer. The calibration curve of eplerenone in Phosphate buffer pH 6.8 was analyzed. Results: The selected range of eplerenone was found to be linear. A regression coefficient (R2) at 245 nm was found to be 0.994. Drug content outcomes additionally discovered uniform in all clusters in a range of 97 % to 98 %, that batches arranged with ERS 100 show great mechanical properties contrast with different polymers however helpless glue properties. The flatness of 4 cm2 patches ranges from 348±0.087 mg to 387±0.527 mg. skin irritation it was produced irritation with negligible erythema following 10 d and unequivocal erythema, promptly obvious edema was produced following 12 d. Conclusion: These after-effects of the in vivo skin irritation study recommended that advanced batch S9 doesn't show any kind of significant disturbance on rodent skin for as long as 14 d and it was securely utilized around 24 h. the optimized batch S9 drug was constantly discharged through the Wistar rodent skin up to 16 hr and the delivery design was like an in vitro dissolution profile of the market product.
Title: FORMULATION, OPTIMIZATION, AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS CONTAINING EPLERENONE
Description:
Objective: The proposed work was aimed at optimization, formulation, and characterization of transdermal patches of eplerenone for efficient transdermal delivery of the drug.
Methods: The log p estimation of eplerenone is 1.
34, it was closer to standard worth.
Log P value in a range of 1 to 4 indicates higher permeation through the skin.
FTIIR study was carried out individually for drug, each polymer, and finished product (Patches) compared eplerenone and FTIR spectra of pure drug and polymer.
The calibration curve of eplerenone in Phosphate buffer pH 6.
8 was analyzed.
Results: The selected range of eplerenone was found to be linear.
A regression coefficient (R2) at 245 nm was found to be 0.
994.
Drug content outcomes additionally discovered uniform in all clusters in a range of 97 % to 98 %, that batches arranged with ERS 100 show great mechanical properties contrast with different polymers however helpless glue properties.
The flatness of 4 cm2 patches ranges from 348±0.
087 mg to 387±0.
527 mg.
skin irritation it was produced irritation with negligible erythema following 10 d and unequivocal erythema, promptly obvious edema was produced following 12 d.
Conclusion: These after-effects of the in vivo skin irritation study recommended that advanced batch S9 doesn't show any kind of significant disturbance on rodent skin for as long as 14 d and it was securely utilized around 24 h.
the optimized batch S9 drug was constantly discharged through the Wistar rodent skin up to 16 hr and the delivery design was like an in vitro dissolution profile of the market product.

Related Results

OPTIMIZATION, FORMULATION AND CHARACTERIZATION OF NANO BASED TDDS OF EPLERENONE
OPTIMIZATION, FORMULATION AND CHARACTERIZATION OF NANO BASED TDDS OF EPLERENONE
Objective: The proposed work was aimed to formulation, characterization and optimization of transdermal patches of nanoparticles of eplerenone for efficient transdermal delivery of...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Recent Advances in Transdermal Drug Delivery Systems
Recent Advances in Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS), particularly transdermal patches, represent a significant advancement in pharmaceutical technology, offering non-invasive drug administrat...
KARAKTERISASI POLIMER L-3,4-dihydroxyphenylalanine (L-DOPA) PADA SISTEM PENGHANTARAN OBAT SEDIAAN PATCH TRANSDERMAL
KARAKTERISASI POLIMER L-3,4-dihydroxyphenylalanine (L-DOPA) PADA SISTEM PENGHANTARAN OBAT SEDIAAN PATCH TRANSDERMAL
Abstract. Vitamin B1 is one type of active substance needed by the body but has low Bioaccessibility when used orally. So, to prevent damage to the active vitamin B1 due to gastric...
Eplerenone Suppresses Salt-Induced Vascular Endothelial Growth Factor Expression in the Kidney
Eplerenone Suppresses Salt-Induced Vascular Endothelial Growth Factor Expression in the Kidney
<i>Background/Aim:</i> It is well accepted that high dietary salt intake accelerates both hypertension and target organ damage. We have previously shown that eplerenone...
ROLE OF ORAL EPLERENONE IN THE MANAGMENT OF CENTRAL SEROUS CHORIORETINOPATHY
ROLE OF ORAL EPLERENONE IN THE MANAGMENT OF CENTRAL SEROUS CHORIORETINOPATHY
Background: Central serous chorioretinopathy (CSCR) is a retinal disorder characterized by serous detachment of the neurosensory retina due to choroidal hyperpermeability and dysfu...
Evaluation Of Nanoparticles, Liposomes, Or Transdermal Patches For Improved Bioavailability.
Evaluation Of Nanoparticles, Liposomes, Or Transdermal Patches For Improved Bioavailability.
Background: pharmacology achieving the desired therapeutic effect of a drug is hindered by the difficulties associated with poor bioavailability, particularly with low-solubility a...
TERMINALIA ARJUNA TRANSDERMAL MATRIX FORMULATION CONTAINING DIFFERENT POLYMER COMPONENTS
TERMINALIA ARJUNA TRANSDERMAL MATRIX FORMULATION CONTAINING DIFFERENT POLYMER COMPONENTS
Objective: The objective of this research work was to prepare a transdermal matrix formulation containing different polymer components for topical delivery. Methods: Terminal...

Back to Top